IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 49 filers reported holding IMMUNE DESIGN CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,903,000 | -11.7% | 280,500 | -16.8% | 0.51% | -5.9% |
| Q2 2017 | $3,286,000 | +43.4% | 337,000 | 0.0% | 0.54% | +63.7% |
| Q1 2017 | $2,292,000 | -3.7% | 337,000 | -22.2% | 0.33% | +3.7% |
| Q4 2016 | $2,381,000 | -27.5% | 432,990 | 0.0% | 0.32% | -11.3% |
| Q3 2016 | $3,282,000 | -7.1% | 432,990 | 0.0% | 0.36% | -27.7% |
| Q2 2016 | $3,533,000 | +43.8% | 432,990 | +129.1% | 0.50% | +35.4% |
| Q1 2016 | $2,457,000 | -35.3% | 189,000 | 0.0% | 0.37% | -18.5% |
| Q4 2015 | $3,795,000 | +64.6% | 189,000 | 0.0% | 0.45% | +23.4% |
| Q3 2015 | $2,306,000 | -40.9% | 189,000 | 0.0% | 0.37% | -29.1% |
| Q2 2015 | $3,903,000 | +55.4% | 189,000 | +58.8% | 0.52% | +33.8% |
| Q1 2015 | $2,512,000 | -41.7% | 119,000 | -15.0% | 0.39% | -41.6% |
| Q4 2014 | $4,309,000 | +22.0% | 140,000 | -30.0% | 0.66% | -8.5% |
| Q3 2014 | $3,532,000 | – | 200,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
| Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
| BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
| EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
| Abingworth LLP | 352,300 | $458,000 | 0.42% |
| Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
| ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |